Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
By J. Colombel, P. Rutgeerts, W. Reinisch, D. Esser, Yanxin Wang, Y. Lang, C. Marano, R. Strauss, B. Oddens, B. Feagan and 5 more. Gastroenterology, 2011
912 citations recorded by the source corpus.
Subfields: Epidemiology, Gastroenterology, Genetics
View Paper: https://www.semanticscholar.org/paper/dfb63078651608b1ca45076e06f906ea1d6a9174
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Gastroenterology
In Genetics
Citations in the corpus
- Mucosal healing in inflammatory bowel diseases: a systematic review (2012, background): “Interestingly (in spite of inter-observer variation), a Mayo Clinic endoscopy subscore of 0 discriminated a score of 1 with regard to symptoms and steroid-dependency, although not colectomy: an endoscopy subscore of 0 at week 8 predicted symptom relief (stool frequency or 1e2 more than normal each d”
- ACG Clinical Guideline: Ulcerative Colitis in Adults (2019, background): “The STRIDE recommendations to set endoscopic remission as a primary target were based on evidence that supports that the degree of mucosal healing is correlated with clinical outcomes, including avoiding colectomy (57,58,80).”